Evidence map›Paper›PMID 18353416›Full record

ArticleVirology2008

Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.

Olga A Nikolaitchik, Robert J Gorelick, Maria G Leavitt, Vinay K Pathak, Wei-Shau Hu

Open access · greenAbstract readComparative Study
In one paragraph

Article in Virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Olga A NikolaitchikHIV Drug Resistance Program, Frederick, MD 21702, USA.
Robert J Gorelick
Maria G Leavitt
Vinay K Pathak
Wei-Shau Hu
United States Food and Drug Administration · USNational Cancer Institute · US

Funding

SEA Influenza Clinical Research NetworkN01CO12400 · NCI · LEIDOS BIOMEDICAL RESEARCH, INC. · 2007 to 2008
$225.2M
Understanding Retroviral Gag and RNA Targeting and Virus AssemblyZIABC010506 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, WEI-SHAU · 2009 to 2025
$12.1M
HIV Recombination, Double Infection, and Replication FitnessZ01BC010504 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, WEI-SHAU · 2003 to 2008
$1.1M
Virus Assembly, RNA Packaging, and ReplicationZ01BC010506 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, WEI-SHAU · 2003 to 2008
$819k
Understanding the Pseudodiploidy of the Retroviral GenomeZ01BC010814 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, WEI-SHAU · 2007 to 2008
$819k
Mechanisms of HIV-1 Reverse TranscriptionZIABC010533 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PATHAK, VINAY K. · 2009 to 2011
$407k
Structural Determinants of RT That Influence Fidelity ofZ01BC010533 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PATHAK, VINAY K. · 2003 to 2008
$233k
Intramural NIH HHS Z01 BC010504Intramural NIH HHS Z01 BC010506Intramural NIH HHS Z01 BC010533Intramural NIH HHS Z01 BC010814NCI NIH HHS N01 CO012400NCI NIH HHS N01 CO 12400
6 · The paper itself

Abstract

During human immunodeficiency virus type 1 (HIV-1) assembly, the nucleocapsid (NC) and the PTAP motif in p6 of Gag play important roles in RNA encapsidation and virus release, respectively. We have previously demonstrated that functional complementation occurs between an NC mutant and a PTAP mutant to rescue viral replication. In this report, we examined the amounts of functional NC and PTAP motif that are required during virus replication. When NC and PTAP mutants were coexpressed at 5:1, 5:5, and 1:5 ratios, virus titers were rescued at 5%, 51%, and 86% of the wild-type level, respectively. These results indicate that HIV-1 requires a small amount of functional PTAP motif but far more functional NC to complete efficient replication. Further analyses reveal that RNA packaging can be significantly rescued in viruses containing a small amount of functional NC. However, most of the NC proteins must be functional to generate the wild-type level of R-U5 DNA product. Once the R-U5 product is generated, viruses containing half of the functional NC can complete reverse transcription and DNA integration at near-wild-type efficiency. These results define the quantitative requirements of NC and p6 during HIV-1 replication and provide insights into the requirement for the development of anti-HIV strategies using NC and p6 as targets.

Indexed as

Cell Linegag Gene Products, Human Immunodeficiency VirusHIV-1HumansNucleocapsidProtein Structure, TertiaryRNA, ViralVirus Assemblygag Gene Products, Human Immunodeficiency Virusp6 gag protein, Human immunodeficiency virus 1RNA, Viral

Identifiers

PMID18353416
PMCPMC2459335
OpenAlexW2072611668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.